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Few lives at the top of chemistry and 
industrial accomplishments in the 20th 
century have been as remarkable as 
that of Carl Djerassi, who died in San 
Francisco on January 30 at the age 
of 91. To a considerable extent, his 
life became known as ‘fascinating’, 
catalyzed by his own portrayal of it. 
This feature of his persona cannot, and 
will not, dilute the one major scientifi c 
contribution he made, but it somewhat 
obfuscated the true picture.
 Djerassi was born in 1923 in Vienna 
to secular Jewish parents who were 
physicians. After a brief move to Bulgaria, 
his father’s birthplace, Djerassi and his 
mother returned to Vienna for its cultural 
richness, including the superior schooling 
available. After the annexation of Austria 
by Nazi Germany, his mother and he 
were among the quota for evacuation 
to America. Now 16, Djerassi promptly 
displayed an example of the bravado 
that would typify his career and life — he 
sought the intercession of none other than 
Eleanor Roosevelt for college fi nancial 
assistance, successfully. After a short stint 
at Tarkio College in Missouri, where he 
earned a bit of additional money by giving 
lectures on Bulgaria and Europe to church 
groups, he obtained a degree in chemistry 
from Kenyon College in Ohio, followed by 
a job at the American branch of the Swiss 
pharmaceutical company Ciba in Summit, 
New Jersey. Here, he was part of a group 
that developed pyribenzamine, a major 
antihistamine. He stayed at Ciba only a 
year and then pursued and obtained a 
Ph.D. from the University of Wisconsin in 
1945, followed by a return to Ciba for the 
next three years.
 By the late 1940s, word of Djerassi’s 
talent had spread, notably at the annual 
Laurentian Hormone Conferences in 
Quebec, where one of several with open 
ears was the steroid chemist George 
Rosenkranz. He had been appointed in 
1945 to lead a newly formed company, 
Syntex, whose goal was to pursue the 
production of steroids from plant sources, 
the most timely of such quarries being 
cortisone. Djerassi joined this intrepid 
outfi t in 1949 and its fortunes soon rose. 
ObituaryC Beyond cortisone, Syntex and 
its precursor company had been 
interested in progesterone, the steroid 
hormone that maintains the condition of 
pregnancy. It had long been suspected 
that administration of exogenous 
progesterone might produce a 
contraceptive state. Although available or 
readily converted from plant sources — 
chemical achievements by Syntex’s co-
founder Russell Marker — progesterone 
itself had limitations for an oral delivery-
based pharmaceutical. In 1951, Djerassi 
and Luis Miramontes, a student doing 
his Ph.D. at the company, synthesized 
multigrams of the progesterone derivative 
19-norprogesterone, with the means 
of evicting the methyl group at position 
19 perhaps having been conveyed to 
Djerassi by his former Ph.D. adviser A.L. 
Wilds. They then attached an ethynyl 
group at position 17, which was correctly 
anticipated to boost the compound’s 
oral effi cacy. A historical point often 
overlooked is that Syntex’s initial interest 
in orally-active progesterone analogs 
was based on their envisioned use in 
the treatment of certain gynecological 
and menstrual conditions, not to induce 
a contraceptive state. But the latter 
potential soon became evident and 
this shifted Syntex’s fortunes into high 
gear, particularly since the quest for the 
production of cortisone had been won by 
Merck in 1949.
 The Djerassi team’s process for 
19-nor-17-ethynyltestosterone 
(norethindrone), and the patent that 
protected it, launched Syntex into the 
oral contraceptive market. This project, 
led by Djerassi, is the basis for his 
correct claim that they were the fi rst 
to synthesize the steroid that became, 
later, the basis for one of the fi rst two 
oral contraceptives (the Syntex pill being 
second to one brought to market by G.D. 
Searle). Some objected to Djerassi’s 
self-portrayal as ‘the father’ of the Pill. 
He, however, was always careful to state 
that his achievement was being the fi rst 
to synthesize a compound that would 
become one of the oral contraceptives. 
In addition, he gracefully conceded in 
his several autobiographies that a more 
correct term was ‘a’ father, giving proper 
credit to Gregory Pincus and M.C. 
Chang at the Worcester Foundation and 
characterizing both Pincus and himself 
as ‘fathers’. 
 Djerassi, like most industrial chemists, 
held no invention rights of his own urrent Biology 25, R255–R268, March 30, 2015but bought shares in the company. In 
due course, he became both wealthy 
and world famous. He used these two 
stations vivaciously all through the 
remainder of his life.
 By the time of Syntex’s zenith, Djerassi 
had become a Professor at Stanford 
University where he displayed an 
astonishing level of research productivity. 
He also was a prolifi c classroom teacher, 
welcoming a heavy load, not only in 
chemistry but also in an inspired human 
biology course he created that was wildly 
popular (students had to apply with an 
essay and only half got in). He trained 
more than 300 graduate students in 
his overall career and, within the guild, 
became internationally recognized for his 
work on the application of spectroscopic 
methods to organic chemistry, in parallel 
with the wider fame he acquired in the 
Syntex era. 
 With time, Djerassi increasingly 
became a public statesman of science, 
particularly around the Pill and the social 
revolution it had created. He bought a 
vast tract of land overlooking the Pacifi c, 
naming it ‘SMIP’ (for ‘Syntex Made it 
Possible’), where he hosted artists and 
other intellectuals and assembled a 
fi ne collection of paintings, especially 
by Paul Klee. In these years, he also 
embarked on an admirable philanthropic 
strand in his life, which he continued. 
But his greatest passion during this 
phase of his life and afterwards was 
writing fi ction and then plays — the 
promotion of which he undertook 
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centered on science and/or the fl aws 
of its practitioners, often coupled with 
broader societal themes. He staged 
his plays in Vienna, London and New 
York and elsewhere, and had hoped 
to have reviews like Michael Frayn got 
for ‘Copenhagen’, for example, but 
these did not come. He also wrote four 
autobiographical works and in the fi nal 
one, published only months before his 
death, Djerassi delved into his motives 
behind these endeavors in fi ction and 
on the stage. One can admire him for 
the cleverness of his novels and plays, 
as well as a well-intended desire to 
convey science and its culture, but there 
was often a certain ponderous tone to 
the dialogue. Djerassi wanted his plays 
to not only be applauded by critics 
for their virtues as pure theater, but to 
have them be seen as exemplars of his 
statesmanship for the cause of science, 
analogous to the contributions of J.B.S. 
Haldane as an essayist or Carl Sagan 
as a populist. He may have fallen short 
on both of these laudable goals, but his 
endeavors deserve admiration. 
Any chemist of Djerassi’s 
accomplishment would hope for esteem 
in the guild, and this he surely had, as 
well as a wider circle beyond chemistry, 
including sociology. He received many 
honors including both the U.S. National 
Medal of Science and National Medal 
of Technology, and the fi rst Wolf Medal 
of Israel. As one who always referred 
to himself, correctly, as a displaced 
person, these surely were signifi cant. 
In the last decades of his life, Djerassi’s 
unquenchable intensity was manifest 
by a very active triangulation between 
Vienna, London and San Francisco, 
even as his fi nal illness began to close 
in. Indeed, after his death his calendar 
was found to have entries of numerous 
lectures and trips scheduled way into 
2015. He was predeceased by three 
wives and a daughter, and is survived by 
a son, grandson and stepdaughter.
Carl Djerassi gave very much to 
the world. He was as complex as he 
candidly portrayed himself, and leaves 
us saddened that we will no longer have 
the man and his works to surprise and 
stimulate us.
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What turned you on to biology in 
the fi rst place? I have always been 
fascinated by the biology and behaviour 
of animals (including humans). In 
particular, I have always felt driven to 
understand how biological mechanisms 
support complex cognitive processes 
such as conscious thought. 
And what drew you to your 
specifi c fi eld of research? Early 
on I decided that conscious thought 
might be beyond our reach in current 
experimental neurobiology; however, 
conscious recollection — everyday 
memory — seemed more tractable and 
a good place to start investigating the 
neurobiology of high-order cognition. 
So, I quickly focused on the biological 
mechanisms of memory.
Who were your key early infl uences? 
I had the good fortune of interacting 
with three pioneers in the neurobiology 
of memory during my PhD training at 
the University of Michigan during the 
1970s. My PhD supervisor Bernard 
Agranoff had discovered key steps in 
the molecular biology of memory, and 
early on in my training we were visited 
by Brenda Milner, who discussed her 
observations on memory loss following 
removal of the hippocampal area in the 
famous patient H.M. It became clear 
to me that I should pursue the territory 
between the molecular–cellular and the 
brain system levels to understand how 
the cellular mechanisms of neuronal 
activity support the phenomenology 
of memory. A promising avenue h 30, 2015 ©2015 Elsevier Ltd All rights reservfor this approach presented itself 
when I became aware of the work of 
Michigan’s James Ranck, one of the 
pioneers in recording single neuron 
activity in the hippocampus of behaving 
rats. I was captivated by listening to 
neurons fi re during ongoing behaviour 
and by the possibility of discovering 
the neural ‘code’ for memories as the 
bridge between cellular mechanisms 
and cognitive phenomena in memory. 
Do you have any neuroscience 
heroes? Among my heroes are the 
pioneers I met early in my career, and 
others who made major breakthroughs 
in this fi eld, including James McGaugh, 
who pioneered neurobiological studies 
on memory consolidation, and Neal 
Cohen and Larry Squire whose 
studies on amnesia led a revolution 
in distinguishing multiple memory 
systems in the brain. I’ll say a little more 
about James Ranck (in whose lab I 
fi rst listened to hippocampal neurons 
fi ring in behaving rats). In 1973, he 
published an insightful and detailed (70 
pages) categorization of the behavioural 
correlates of hippocampal neuronal 
activity. In it, Ranck commented that 
spatial fi ring characteristics described 
in a preliminary report by John O’Keefe 
could be the entire basis of the apparent 
behavioural properties he had observed. 
Ranck’s elegant observations on 
complex natural behaviours encoded by 
hippocampal neurons was subsequently 
lost in the excitement about place cells, 
but his intuitions opened a window to 
the broad range of experience captured 
in hippocampal neuronal activity. 
Which historical scientist would 
you like to meet and what would 
you ask her or him? In the fi eld of 
hippocampal research, there are two 
prominent views. One view, based 
on the observations on amnesic 
patient H.M., is that the hippocampus 
supports memory. The other view 
is based on O’Keefe’s discovery of 
hippocampal place cells — neurons 
that fi re when an animal occupies a 
specifi c location in its environment. To 
O’Keefe and his followers, place cells 
are the neural substrate for a mapping 
of physical space, a potential neural 
implementation of the ‘cognitive map’ 
concept introduced by the psychologist 
Edward Tolman in the 1930s and 1940s. 
But Tolman characterized cognitive ed
